ArticleDrug and alcohol dependence2025
Over-the-counter naloxone availability at North Carolina community pharmacies: A secret shopper study.
Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Public perceptions and willingness-to-pay regarding over-the-counter (OTC) naloxone: A national cross-sectional survey informed by the Theory of Planned Behavior.Exploratory research in clinical and social pharmacy · 2026Article
- Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status.JAMA network open · 2026Article
- Over-the-counter naloxone sales and pricing variability in North Carolina following FDA approval.Journal of substance use and addiction treatment · 2026Article
- "With a little help from my friends" - collaborating with community experts to improve sampling and obtain a high response rate for a statewide naloxone availability survey.BMC public health · 2026Article
- Navigating Hepatitis C care: Knowledge gaps and access barriers among young women who inject drugs in rural Appalachia.PloS one · 2025Article
- Availability and cost of naloxone over time: A longitudinal secret shopper study in North Carolina community pharmacies.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOver-the-counter (OTC) naloxone became available for sale at community pharmacies in September 2023. This study examines whether naloxone availability and cost are associated with pharmacy type (independent vs chain), pharmacy rurality, and their interaction.
methodsUsing a cross-sectional secret shopper study design, data were collected by phone from a stratified random sample of 600 community pharmacies in North Carolina from November 2023 to January 2024. Trained secret shoppers enacted a standardized script and documented whether the pharmacy: dispensed naloxone, sold OTC naloxone, and offered same-day pick-up. Shoppers also documented the location of OTC naloxone and out-of-pocket cost. Generalized Estimating Equations (GEEs) were used to examine whether naloxone availability and cost varied by pharmacy type (independent vs chain), rurality (urban, suburban, rural), and a rurality*type interaction.
resultsSampled pharmacies were 48.5 % urban, 11.7 % suburban, and 39.7 % rural, with 50.4 % being chain, 48.2 % independent, and 1.4 % health department pharmacies. Among the 500 pharmacies that sold naloxone, 57.4 % sold the OTC product, which was primarily stored behind-the-counter (62.5 %). Same-day pick-up was available at 82.8 % of pharmacies. In GEE models, rurality was not significant. However, independent pharmacies were significantly less likely than chain pharmacies to sell naloxone, have same-day pick-up, and store OTC naloxone on-the-shelf. Interaction terms were not significant, suggesting that the effect of pharmacy type on naloxone availability and cost did not vary by rurality.
conclusionsPharmacy type, not rurality, was consistently associated with naloxone access and out-of-pocket cost. Interventions should address barriers to naloxone access and cost at independent pharmacies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.